Table 1.

Demographics at Time of TCD.

ID	Age	Sex	Race / Ethnicity	BI	SI	EI	TCD Sessions *	Hgb	ASP	Epilepsy	AED	Developmental and cognitive delays
1	8 mos	M	C	L - F, T	L	-	One	13.0	N	Y	OCBZ, LVT	Developmental delays
2	10 mos	F	C	R - O, P, T	R	R	One	14.3	Y	N	-	No cognitive delays
3	3 yrs 5 mos	M	C	R - F, O, P, T	-	-	One	-	N	Y	CBZ	Mild cognitive impairment
4	3 yrs 1 mos	F	C	L - F, P, O, T	B	L	Two	11.6	Y	Y	LVT, OCBZ	No cognitive delays
5	7 yrs 9 mos	F	C	R - O, P, T	R	R	One	-	Y	Y	OCBZ	No cognitive delays
6	7 yrs 8 mos	M	C	R - P, O, T	B	B	Two	13.2	Y	Y	LVT, OCBZ	Borderline intellectual abilities
7	7 yrs 6 mos	M	ASAM	L - F, P, T	L	-	Two	12.8	Y	Y	OCBZ	Learning disabilities
8	9 yrs 4 mos	M	C	L - O, P	-	-	One	-	N	Y	TPM	Learning disabilities
9	9 yrs 2 mos	M	AA	L - P, O	L	L	Two	12.9	Y	Y	OCBZ	Borderline intellectual abilities and ADHD
10	10 yrs 5 mos	F	C	R - F, P, O, T	R	B	Two	13.8	N	Y	CBZ	Mild cognitive impairment
11	11 yrs 2 mos	F	C	R - F	B	B	Two	13.7	N	N**	-	ADD and learning disabilities
12	13 yrs 10 mos	F	ASAM	R - P, O	-	-	Two	13.4	Y	Y	OCBZ	No cognitive delays
13	17 yrs 3 mos	M	AA	R - P, O	-	-	Two	14.9	Y	Y	LMT, TPM, OCBZ	Borderline intellectual abilities
14	20 yrs 6 mos	F	C	L - F, P, O, T	L	R	Two	12.8	Y	Y	CBZ, TPM	ADD

BI – Brain Involvement

ASP – Aspirin (3 – 5 mg/kg/day)

C – Caucasian

B – Bilateral

P – Parietal lobe

CBZ – Carbamazepine

ADHD – Attention Deficit Hyperactivity Disorder

SI – Skin Involvement

AED – Anticonvulsants

ASAM – Asian American

F – Frontal lobe

Y – Yes N – No

TPM – Topiramate

EI – Eye Involvement

yrs – years mos – months

AA – African American

T – Temporal lobe

OCBZ – Oxcarbazepine

LMT – Lamotrigine

ADD – Attention Deficit Disorder

Hgb – Hemoglobin (g/dL)

M – Male F – Female

L – Left R – Right

O – Occipital lobe

LVT – Levetiracetam

^*Nine subjects had two TCD sessions in the same day. Five subjects had one TCD session.

^**Patient had seizures at one month of age and was weaned off Phenobarbital at 2 ½ year of age. No seizures since